Ads
related to: abbvie stock
Search results
Pharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
Zacks via Yahoo Finance Canada· 22 hours agoEli Lilly (LLY) wins FDA approval for its Alzheimer's disease drug, Kisunla. (donanemab). Sanofi...
Continuous bioprocessing set to revolutionize cGMP manufacturing of biologics
BioPharma-Reporter· 24 hours agoConsequently commercial demands of many of these next generation therapeutics are lower, ranging...
2 Boston Partners Mutual Funds for Maximum Returns
Zacks via Yahoo Finance Canada· 1 day agoRamallo has been the lead manager of BPAVX since Dec 30, 2007. Most of the fund’s holdings were in companies like Johnson & Johnson (2.2%), JPMorgan...
Cerevel Sued Over Stock Sale to Bain Ahead of AbbVie Deal News
Bloomberg Law· 3 days agoBain Capital LP affiliates may have arranged to buy stock on the cheap when they knew Cerevel Therapeutics Holdings Inc. was set to be acquired by AbbVie Inc. for $8.7 billion, a newly filed lawsuit says.
Company News for Jul 3, 2024
Zacks via Yahoo Finance Canada· 3 days agoShares of Apple Inc. AAPL rose 1.6% on the continued mega-cap growth stock rally. iQIYI, Inc.’s IQ shares rose 1.4% on consumer discretionaries scoring a...
MedinCell And Two More Euronext Paris Growth Stocks With High Insider Ownership
Simply Wall St. via Yahoo Finance Canada· 3 days agoAs the French market navigates through a period of political uncertainty with upcoming elections,...
With 72% ownership, AbbVie Inc. (NYSE:ABBV) boasts of strong institutional backing
Simply Wall St. via Yahoo Finance Canada· 4 days agoKey Insights Significantly high institutional ownership implies AbbVie's stock price is sensitive to...
Top Insider-Owned Growth Companies On Euronext Paris July 2024
Simply Wall St. via Yahoo Finance Canada· 4 days agoAmid a backdrop of heightened political uncertainty and fluctuating market indices, France's...
AbbVie (ABBV) Gets CHMP Nod for Lymphoma Drug's Expanded Use
Zacks via Yahoo Finance Canada· 5 days agoAbbVie (ABBV) is seeking approval for Tepkinly in the EU as a monotherapy for the treatment of adult...